Skip to main content
PRIVI SPECIALITY CHEMICALS LIMITED logo

PRIVI SPECIALITY CHEMICALS LIMITED — Investor Relations & Filings

Ticker · PRIVISCL ISIN · INE959A01019 LEI · 254900CXKZNRRKIC1Z55 BSE.NS Manufacturing
Filings indexed 686 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country IN India
Listing BSE.NS PRIVISCL

About PRIVI SPECIALITY CHEMICALS LIMITED

https://privi.com/

Privi Speciality Chemicals Limited specializes in the development, manufacture, and export of aroma chemicals. The company produces a diverse range of fragrance and flavor ingredients, utilizing advanced chemical processes such as hydrogenation, oxidation, and distillation. Its product portfolio features Pinene-based chemicals, Citral derivatives, and Sandalwood substitutes, including key molecules like Dihydromyrcenol and Amber chemicals. Privi maintains vertically integrated manufacturing operations and dedicated research and development centers to ensure product consistency and innovation. The company supplies essential ingredients to global fragrance houses and multinational consumer goods corporations for use in personal care, home care, and fine fragrance applications. Its operations emphasize sustainable chemical synthesis and high-purity standards to meet the requirements of the global flavor and fragrance market.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 85% confidence The document comprises a series of compliance letters from the promoters of Privi Speciality Chemicals Ltd. to BSE and NSE, submitting their annual disclosures under Regulation 31(4) of SEBI (SAST) Regulations, 2011. These filings are regulatory announcements of encumbrance status (or lack thereof) and PAN details, not announcements of threshold crossings, share issues, director transactions, or substantive financial reports. Therefore, they fall under the miscellaneous regulatory filings category.
2026-05-29 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 85% confidence The document consists of multiple letters from the company’s promoters and promoter‐group to stock exchanges providing their annual disclosures under SEBI (SAST) Regulation 31(4) for the year ended March 31, 2026. These are compliance submissions (encumbrance disclosures) rather than financial reports, corporate actions, or share transactions. It does not change shareholding thresholds, announce dividends, management changes, or any merger/financing activity. Therefore it best fits into the generic “Regulatory Filings” category (RNS).
2026-05-26 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 90% confidence The document consists of multiple letters providing annual disclosures under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, from the promoter/promoter group stating that no encumbrances were created on equity shares during the financial year ended March 31, 2026. This is a statutory compliance filing with stock exchanges rather than a financial report, earnings release, share issue, or insider transaction. It does not announce a change in shareholding thresholds, dividend, or capital structure, nor does it contain substantive financial data. Therefore, it falls under general regulatory announcements and compliance documents. Classification: RNS.
2026-05-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is an intimation to stock exchanges under SEBI Listing Obligations about scheduled analyst/investor meetings. It contains no financial statements or substantive report content; it is a routine regulatory announcement. It does not fit earnings releases, presentations, or financial reports. It is a miscellaneous regulatory filing under LODR, so it falls into the Regulatory Filings (RNS) category.
2026-05-21 English
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.
Regulatory Filings Classification · 62% confidence The document is an intimation to the stock exchanges under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, notifying the schedule of analyst/institutional investor meetings. It is a routine regulatory compliance announcement rather than a financial report, earnings release, or specific corporate action. Therefore it best fits the general “Regulatory Filings” category (RNS) as a compliance disclosure under listing rules.
2026-05-21 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 72% confidence The document consists of letters from company promoters to the BSE and NSE under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, declaring their shareholding status (zero shares/encumbrances) as at the financial year ended March 31, 2026. This is a statutory disclosure regarding shareholding. Although no threshold crossing occurred, it is a formal shareholding notification under takeover regulations. The appropriate category is Major Shareholding Notification (MRQ).
2026-05-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.